PRODUCT DETAIL

Azelastín/Flutikazón Teva 137 mikrogramov/50 mikrogramov

Code

4707E

MA number

24/0242/23-S

Product Form:

aer nau 3x23 g (fľ.skl.jantár. - multibal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

Teva B.V., Netherland

Therapeutic Class:

24 - ANTIHISTAMINICA, HISTAMIN

ATC:

R	RESPIRATORY SYSTEM
R01	NASAL PREPARATIONS
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD	Corticosteroids
R01AD58	Fluticasone,combinations

Shelf life:

Container:

amber glass bottle

Route of admin.:

Nasal use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(3) hybrid application
MA issued:	23.10.2023
Validity:	23.10.2028
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Azelastín_Flutikazón Teva 137 mikrogramov_50 mikrogramov_10_2023.pdf
PIL:	PIL_Azelastín/Flutikazón Teva 137 mikrogramov/50 mikrogramov_05/2025.pdf
Safety feature	Yes
Data update:	14.11.2023